Editorial · 31 May 2025
OpinionPublished 30 Nov 2022
Molecular histology of lung cancer and progress in lung cancer treatments.
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Lung cancer in the lungs endurance has just hardly worked on throughout recent many years, yet the accessibility of screening and early identification by low-portion PC tomography and advances in designated medicines and immunotherapy will probably diminish death rates and further develop patient endurance results sooner rather than later. Lung cancer in the lungs is the main source of disease mortality.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Medical Oncology and Therapeutics.
Opinion · 31 May 2025
The Importance of Early-Phase Clinical Trials in Developing New Cancer Therapies
Short communication · 31 May 2025
Understanding Cancer Drug Resistance: Mechanisms and Solutions
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Medical Oncology and Therapeutics
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Jonas Muller”
